S. Andrew Boyer's most recent trade in Amneal Pharmaceuticals Inc - Ordinary Shares - Class A was a trade of 125,000 Class A Common Stock done at an average price of $8.9 . Disclosure was reported to the exchange on March 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Sale of securities on an exchange or to another person at price $ 8.89 per share. | 05 Mar 2025 | 125,000 | 290,106 (0%) | 0% | 8.9 | 1,111,250 | Class A Common Stock |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 194,064 | 194,064 | - | - | Performance-Based Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 157,005 | 0 | - | - | Performance-Based Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 157,005 | 476,758 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 97,032 | 97,033 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.76 per share. | 03 Mar 2025 | 80,309 | 396,449 (0%) | 0% | 8.8 | 703,507 | Class A Common Stock |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 49,694 | 99,389 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 49,694 | 345,172 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 39,251 | 39,252 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 39,251 | 315,555 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 38,194 | 114,582 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 38,194 | 434,643 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.76 per share. | 03 Mar 2025 | 25,419 | 319,753 (0%) | 0% | 8.8 | 222,670 | Class A Common Stock |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.76 per share. | 03 Mar 2025 | 20,077 | 295,478 (0%) | 0% | 8.8 | 175,875 | Class A Common Stock |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.84 per share. | 03 Mar 2025 | 19,537 | 415,106 (0%) | 0% | 8.8 | 172,707 | Class A Common Stock |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 31,371 | 0 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 31,371 | 288,041 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.67 per share. | 01 Mar 2025 | 11,737 | 276,304 (0%) | 0% | 8.7 | 101,760 | Class A Common Stock |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Sale of securities on an exchange or to another person at price $ 7.85 per share. | 14 Aug 2024 | 40,225 | 256,670 (0%) | 0% | 7.8 | 315,766 | Class A Common Stock |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Sale of securities on an exchange or to another person at price $ 7.81 per share. | 14 Aug 2024 | 22,486 | 296,895 (0%) | 0% | 7.8 | 175,616 | Class A Common Stock |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 305,556 | 305,556 | - | - | Performance-Based Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 152,778 | 152,778 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 49,694 | 344,278 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 49,694 | 149,083 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 39,251 | 314,249 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 39,251 | 78,503 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 31,371 | 291,217 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 31,371 | 31,371 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.47 per share. | 01 Mar 2024 | 24,897 | 319,381 (0%) | 0% | 5.5 | 136,187 | Class A Common Stock |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.47 per share. | 01 Mar 2024 | 19,665 | 294,584 (0%) | 0% | 5.5 | 107,568 | Class A Common Stock |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.47 per share. | 01 Mar 2024 | 16,219 | 274,998 (0%) | 0% | 5.5 | 88,718 | Class A Common Stock |
| Amneal Pharmaceuticals Inc... | S. Andrew Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2024 | 31,663 | 276,402 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2024 | 31,663 | 0 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | S. Andrew Boyer | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.71 per share. | 27 Feb 2024 | 16,556 | 259,846 (0%) | 0% | 5.7 | 94,535 | Class A Common Stock |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Sale of securities on an exchange or to another person at price $ 4.13 per share. | 11 Aug 2023 | 29,302 | 244,739 (0%) | 0% | 4.1 | 120,921 | Class A Common Stock |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2023 | 23,095 | 285,612 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2023 | 23,095 | 0 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.10 per share. | 30 Jun 2023 | 11,571 | 274,041 (0%) | 0% | 3.1 | 35,870 | Class A Common Stock |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 397,554 | 397,554 | - | - | Performance-Based Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 198,777 | 198,777 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 39,251 | 282,202 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 39,251 | 117,754 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.92 per share. | 03 Mar 2023 | 19,685 | 262,517 (0%) | 0% | 1.9 | 37,795 | Class A Common Stock |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 31,371 | 259,072 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 31,371 | 62,742 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.09 per share. | 01 Mar 2023 | 16,121 | 242,951 (0%) | 0% | 2.1 | 33,693 | Class A Common Stock |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 12,346 | 234,547 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 12,346 | 0 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.09 per share. | 01 Mar 2023 | 6,846 | 227,701 (0%) | 0% | 2.1 | 14,308 | Class A Common Stock |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2023 | 31,662 | 239,758 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2023 | 31,662 | 31,663 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.16 per share. | 27 Feb 2023 | 17,557 | 222,201 (0%) | 0% | 2.2 | 37,923 | Class A Common Stock |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2022 | 23,094 | 219,678 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2022 | 23,094 | 23,095 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.18 per share. | 30 Jun 2022 | 11,582 | 208,096 (0%) | 0% | 3.2 | 36,831 | Class A Common Stock |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2022 | 16,656 | 0 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2022 | 16,656 | 204,937 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.40 per share. | 07 May 2022 | 8,353 | 196,584 (0%) | 0% | 3.4 | 28,400 | Class A Common Stock |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 314,010 | 314,010 | - | - | Performance-Based Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 157,005 | 157,005 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 31,370 | 204,014 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 31,370 | 94,113 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.45 per share. | 01 Mar 2022 | 15,733 | 188,281 (0%) | 0% | 4.5 | 70,012 | Class A Common Stock |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 12,346 | 178,836 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 12,346 | 12,346 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.45 per share. | 01 Mar 2022 | 6,192 | 172,644 (0%) | 0% | 4.4 | 27,554 | Class A Common Stock |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2022 | 31,662 | 63,325 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2022 | 31,662 | 182,924 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.59 per share. | 27 Feb 2022 | 16,434 | 166,490 (0%) | 0% | 4.6 | 75,432 | Class A Common Stock |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2021 | 23,095 | 46,189 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2021 | 23,095 | 162,845 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.12 per share. | 30 Jun 2021 | 11,583 | 151,262 (0%) | 0% | 5.1 | 59,305 | Class A Common Stock |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2021 | 16,655 | 16,656 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2021 | 16,655 | 148,103 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.20 per share. | 07 May 2021 | 8,353 | 139,750 (0%) | 0% | 5.2 | 43,436 | Class A Common Stock |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 250,966 | 250,966 | - | - | Performance-Based Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 125,483 | 125,483 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2021 | 31,662 | 141,595 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2021 | 31,662 | 94,987 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.39 per share. | 27 Feb 2021 | 16,301 | 125,294 (0%) | 0% | 5.4 | 87,862 | Class A Common Stock |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2021 | 12,346 | 24,692 | - | - | Restricted Stock Units | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2021 | 12,346 | 137,640 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.18 per share. | 27 Feb 2021 | 6,192 | 131,448 (0%) | 0% | 5.2 | 32,075 | Class A Common Stock |
| Amneal Pharmaceuticals Inc... | Andrew S. Boyer | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2020 | 69,284 | 102,595 | - | - | Restricted Stock Units |